Page last updated: 2024-10-19

niacinamide and Malignant Carcinoid Syndrome

niacinamide has been researched along with Malignant Carcinoid Syndrome in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Swain, CP1
Tavill, AS1
Neale, G1
Castiello, RJ1
Lynch, PJ1

Other Studies

2 other studies available for niacinamide and Malignant Carcinoid Syndrome

ArticleYear
Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia.
    Gastroenterology, 1976, Volume: 71, Issue:3

    Topics: Adult; Body Weight; Female; Humans; Hypoproteinemia; Malignant Carcinoid Syndrome; Niacinamide; Pell

1976
Pellagra and the carcinoid syndrome.
    Archives of dermatology, 1972, Volume: 105, Issue:4

    Topics: Digitalis Glycosides; Diuretics; Female; Fluorouracil; Humans; Malignant Carcinoid Syndrome; Middle

1972